Literature DB >> 24347803

Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain.

Rodrigo Noseda1, Rami Burstein1.   

Abstract

Scientific evidence support the notion that migraine pathophysiology involves inherited alteration of brain excitability, intracranial arterial dilatation, recurrent activation and sensitization of the trigeminovascular pathway, and consequential structural and functional changes in genetically susceptible individuals. Evidence of altered brain excitability emerged from clinical and preclinical investigation of sensory auras, ictal and interictal hypersensitivity to visual, auditory and olfactory stimulation, and reduced activation of descending inhibitory pain pathways. Data supporting the activation and sensitization of the trigeminovascular system include the progressive development of cephalic and whole-body cutaneous allodynia during a migraine attack. Also, structural and functional alterations include the presence of subcortical white mater lesions, thickening of cortical areas involved in processing sensory information, and cortical neuroplastic changes induced by cortical spreading depression. Here, we review recent anatomical data on the trigeminovascular pathway and its activation by cortical spreading depression, a novel understanding of the neural substrate of migraine-type photophobia, and modulation of the trigeminovascular pathway by the brainstem, hypothalamus and cortex.

Entities:  

Year:  2013        PMID: 24347803      PMCID: PMC3858400          DOI: 10.1016/j.pain.2013.07.021

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  130 in total

1.  Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study.

Authors:  John R Keltner; Ansgar Furst; Catherine Fan; Rick Redfern; Ben Inglis; Howard L Fields
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

2.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

3.  The central projections of trigeminal primary afferent neurons in the cat as determined by the tranganglionic transport of horseradish peroxidase.

Authors:  C F Marfurt
Journal:  J Comp Neurol       Date:  1981-12-20       Impact factor: 3.215

4.  Motor cortex excitability in patients with migraine with aura and hemiplegic migraine.

Authors:  K J Werhahn; K Wiseman; J Herzog; S Förderreuther; M Dichgans; A Straube
Journal:  Cephalalgia       Date:  2000-02       Impact factor: 6.292

5.  Hyperexcitability of the primary somatosensory cortex in migraine--a magnetoencephalographic study.

Authors:  Eberhard Lang; Martin Kaltenhäuser; Bernhard Neundörfer; Sia Seidler
Journal:  Brain       Date:  2004-10-07       Impact factor: 13.501

6.  Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine.

Authors:  J Olesen; B Larsen; M Lauritzen
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

7.  Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus.

Authors:  K D Davis; J O Dostrovsky
Journal:  Brain Res       Date:  1988-06-28       Impact factor: 3.252

8.  Premonitory symptoms in migraine: an electronic diary study.

Authors:  N J Giffin; L Ruggiero; R B Lipton; S D Silberstein; J F Tvedskov; J Olesen; J Altman; P J Goadsby; A Macrae
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

9.  Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.

Authors:  Loredana Leo; Lisa Gherardini; Virginia Barone; Maurizio De Fusco; Daniela Pietrobon; Tommaso Pizzorusso; Giorgio Casari
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

10.  Bright light activates a trigeminal nociceptive pathway.

Authors:  Keiichiro Okamoto; Akimasa Tashiro; Zheng Chang; David A Bereiter
Journal:  Pain       Date:  2010-03-04       Impact factor: 7.926

View more
  44 in total

1.  Altered brainstem auditory evoked potentials in a rat central sensitization model are similar to those in migraine.

Authors:  Xianghong Arakaki; Gary Galbraith; Victor Pikov; Alfred N Fonteh; Michael G Harrington
Journal:  Brain Res       Date:  2014-03-27       Impact factor: 3.252

Review 2.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

4.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

Review 5.  Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

Authors:  Marcelo E Bigal; Sarah Walter
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

6.  Hypothalamic and basal ganglia projections to the posterior thalamus: possible role in modulation of migraine headache and photophobia.

Authors:  R Kagan; V Kainz; R Burstein; R Noseda
Journal:  Neuroscience       Date:  2013-06-25       Impact factor: 3.590

Review 7.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

8.  Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72).

Authors:  M Lukács; K Warfvinge; J Tajti; F Fülöp; J Toldi; L Vécsei; L Edvinsson
Journal:  J Headache Pain       Date:  2017-03-23       Impact factor: 7.277

Review 9.  Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.

Authors:  Greg Dussor
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

10.  Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine.

Authors:  Brett R Martin; David R Seaman
Journal:  J Chiropr Med       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.